9.81
price down icon1.31%   -0.13
after-market Dopo l'orario di chiusura: 9.82 0.010 +0.10%
loading
Precedente Chiudi:
$9.94
Aprire:
$9.9
Volume 24 ore:
2.62M
Relative Volume:
0.47
Capitalizzazione di mercato:
$2.55B
Reddito:
$6.29B
Utile/perdita netta:
$750.00M
Rapporto P/E:
3.4063
EPS:
2.88
Flusso di cassa netto:
$586.00M
1 W Prestazione:
+0.93%
1M Prestazione:
-2.29%
6M Prestazione:
-37.95%
1 anno Prestazione:
-53.94%
Intervallo 1D:
Value
$9.765
$10.01
Intervallo di 1 settimana:
Value
$9.71
$10.27
Portata 52W:
Value
$8.01
$23.10

Organon Co Stock (OGN) Company Profile

Name
Nome
Organon Co
Name
Telefono
551-430-6000
Name
Indirizzo
30 HUDSON STREET, JERSEY CITY
Name
Dipendente
10,000
Name
Cinguettio
Name
Prossima data di guadagno
2024-10-31
Name
Ultimi documenti SEC
Name
OGN's Discussions on Twitter

Confronta OGN con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Drug Manufacturers - General icon
OGN
Organon Co
9.81 2.53B 6.29B 750.00M 586.00M 2.88
Drug Manufacturers - General icon
LLY
Lilly Eli Co
799.34 693.83B 49.00B 11.11B -1.27B 12.29
Drug Manufacturers - General icon
JNJ
Johnson Johnson
156.82 373.59B 89.33B 21.81B 18.57B 8.99
Drug Manufacturers - General icon
ABBV
Abbvie Inc
191.52 331.43B 57.37B 4.20B 15.39B 2.35
Drug Manufacturers - General icon
NVS
Novartis Ag Adr
121.04 241.20B 53.22B 12.86B 14.85B 6.39
Drug Manufacturers - General icon
NVO
Novo Nordisk Adr
68.94 308.01B 43.59B 15.04B 10.74B 3.3766

Organon Co Stock (OGN) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-05-02 Downgrade Evercore ISI Outperform → In-line
2024-09-06 Downgrade JP Morgan Neutral → Underweight
2023-11-03 Downgrade Goldman Buy → Neutral
2023-09-21 Iniziato Barclays Overweight
2023-03-16 Iniziato Raymond James Outperform
2022-10-14 Downgrade BofA Securities Neutral → Underperform
2022-09-06 Aggiornamento Piper Sandler Neutral → Overweight
2022-08-05 Downgrade BofA Securities Buy → Neutral
2022-04-27 Iniziato Goldman Buy
2022-04-06 Ripresa Morgan Stanley Equal-Weight
2021-10-07 Iniziato Piper Sandler Neutral
2021-09-01 Iniziato BofA Securities Buy
2021-07-22 Iniziato Citigroup Buy
2021-06-15 Iniziato JP Morgan Neutral
2021-06-11 Iniziato Morgan Stanley Equal-Weight
2021-06-10 Iniziato Evercore ISI Outperform
Mostra tutto

Organon Co Borsa (OGN) Ultime notizie

pulisher
03:47 AM

Organon & Co. Investors: Please contact the Portnoy Law - GlobeNewswire

03:47 AM
pulisher
12:00 PM

Organon & Co. (OGN) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit - PR Newswire

12:00 PM
pulisher
11:36 AM

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Organon & Co. of Class Action Lawsuit and Upcoming DeadlinesOGN - FinancialContent

11:36 AM
pulisher
10:35 AM

ORGANON & CO. (NYSE: OGN) SHAREHOLDER ALERT Bernstein - GlobeNewswire

10:35 AM
pulisher
10:18 AM

OGN Investors Have Opportunity to Lead Organon & Co. Securities Fraud Lawsuit with the Schall Law Firm - WV News

10:18 AM
pulisher
04:28 AM

Organon & Co. (NYSE:OGN) Given Average Recommendation of “Moderate Buy” by Brokerages - Defense World

04:28 AM
pulisher
03:50 AM

Teacher Retirement System of Texas Decreases Stock Holdings in Organon & Co. (NYSE:OGN) - Defense World

03:50 AM
pulisher
Jul 13, 2025

Organon & Co. (OGN) LawsuitInvestors Urged to Contact Levi & Korsinsky Before July 22, 2025 - Stockhouse

Jul 13, 2025
pulisher
Jul 13, 2025

OGN IMPORTANT DEADLINE: ROSEN, A LONGSTANDING LAW FIRM, Encourages Organon & Co. Investors with Losses in Excess of $100K to Secure Counsel Before Important July 22 Deadline in Securities Class Action – OGN - TradingView

Jul 13, 2025
pulisher
Jul 13, 2025

Class Action Lawsuit Alert: Levi & Korsinsky Reminds Organon & Co. (OGN) Investors of July 22, 2025 Deadline - Stockhouse

Jul 13, 2025
pulisher
Jul 12, 2025

Bragar Eagel & Squire, P.C. Reminds Investors That Class - GlobeNewswire

Jul 12, 2025
pulisher
Jul 12, 2025

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Red Cat, Organon, UroGen and Fortrea and Encourages Investors to Contact the Firm - GlobeNewswire Inc.

Jul 12, 2025
pulisher
Jul 12, 2025

OGN FRAUD ALERT: Organon & Co. 27% Stock Drop Triggers - GlobeNewswire

Jul 12, 2025
pulisher
Jul 12, 2025

Organon & Co. Sued for Securities Law Violations – - GlobeNewswire

Jul 12, 2025
pulisher
Jul 11, 2025

Organon & Co.'s VTAMA Cream: A Breakthrough in Atopic Dermatitis and a Growth Catalyst for OGN - AInvest

Jul 11, 2025
pulisher
Jul 11, 2025

OGN INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC - GlobeNewswire

Jul 11, 2025
pulisher
Jul 11, 2025

Act Now or Risk Losses: Organon Investors Face Critical July 22 Deadline in Securities Fraud Lawsuit - AInvest

Jul 11, 2025
pulisher
Jul 11, 2025

Deadline Alert: Organon & Co. (OGN) Investors Who Lost - GlobeNewswire

Jul 11, 2025
pulisher
Jul 11, 2025

Organon & Co. (OGN) Announces American Academy of Dermatology’s Strong Recommendation for VTAMA Cream - Insider Monkey

Jul 11, 2025
pulisher
Jul 11, 2025

Organon & Co. Securities Fraud Class Action Lawsuit - GlobeNewswire

Jul 11, 2025
pulisher
Jul 10, 2025

Organon & Co. (OGN) Announces Discontinuation of the OG-6219 Clinical Development Program - Yahoo

Jul 10, 2025
pulisher
Jul 10, 2025

EXTENDED CLASS PERIOD: Robbins Geller Rudman & Dowd LLP - GlobeNewswire

Jul 10, 2025
pulisher
Jul 09, 2025

ORGANON SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuits Against Organon & Co.OGN - GlobeNewswire

Jul 09, 2025
pulisher
Jul 09, 2025

Is Trending Stock Organon & Co. (OGN) a Buy Now? - Yahoo Finance

Jul 09, 2025
pulisher
Jul 07, 2025

Organon & Co. Sued for Securities Law ViolationsContact - GlobeNewswire

Jul 07, 2025
pulisher
Jul 07, 2025

OGN Shareholders Have the Right to Lead the Organon & Co. Securities LawsuitContact the DJS Law Group to Discuss Your RightsOGN - Morningstar

Jul 07, 2025
pulisher
Jul 07, 2025

With 79% ownership of the shares, Organon & Co. (NYSE:OGN) is heavily dominated by institutional owners - Yahoo Finance

Jul 07, 2025
pulisher
Jun 30, 2025

OGN Stock News: Robbins LLP Reminds Organon & Co. Investors - GlobeNewswire

Jun 30, 2025
pulisher
Jun 27, 2025

INVESTOR DEADLINE: Robbins Geller Announces that Organon & - GlobeNewswire

Jun 27, 2025
pulisher
Jun 25, 2025

Organon & Co. (OGN) is Attracting Investor Attention: Here is What You Should Know - Yahoo Finance

Jun 25, 2025
pulisher
Jun 19, 2025

ORGANON & CO. (NYSE: OGN) INVESTOR ALERT: Investors With - GlobeNewswire

Jun 19, 2025
pulisher
Jun 18, 2025

ORGANON SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Organon & Co.OGN - TradingView

Jun 18, 2025
pulisher
Jun 18, 2025

ROSEN, A RANKED AND LEADING FIRM, Encourages Organon & Co. Investors to Secure Counsel Before Important Deadline in Securities Class Action – OGN - TradingView

Jun 18, 2025
pulisher
Jun 18, 2025

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Organon & Co.of Class Action Lawsuit and Upcoming DeadlinesOGN - TradingView

Jun 18, 2025
pulisher
Jun 18, 2025

July 22, 2025 Deadline: Contact The Gross Law Firm to Join Class Action Suit Against OGN - GlobeNewswire

Jun 18, 2025
pulisher
Jun 18, 2025

INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Organon - GlobeNewswire

Jun 18, 2025
pulisher
Jun 18, 2025

Yousif Capital Management LLC Cuts Position in Organon & Co. (NYSE:OGN) - Defense World

Jun 18, 2025
pulisher
Jun 18, 2025

Organon: A Look Beyond The Dividend Cut (NYSE:OGN) - Seeking Alpha

Jun 18, 2025
pulisher
Jun 17, 2025

ORGANON SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY - GlobeNewswire

Jun 17, 2025
pulisher
Jun 17, 2025

Investors who lost money on Organon & Co.(OGN) should contact Levi & Korsinsky about pending Class ActionOGN - PR Newswire

Jun 17, 2025
pulisher
Jun 17, 2025

Organon: Persistent Headwinds Make This A Hold - Seeking Alpha

Jun 17, 2025
pulisher
Jun 17, 2025

Investor Alert: Deadline Approaching to Join Organon & Co. (OGN) Class ActionContact Levi & Korsinsky - ACCESS Newswire

Jun 17, 2025
pulisher
Jun 16, 2025

OGN Investors Have Opportunity to Lead Organon & Co. Securities Fraud Lawsuit - PR Newswire

Jun 16, 2025
pulisher
Jun 16, 2025

Organon (OGN) Exceeds Market Returns: Some Facts to Consider - Yahoo Finance

Jun 16, 2025
pulisher
Jun 16, 2025

Class Action Filed Against Organon & Co. (OGN)July 22, 2025 Deadline to Join – Contact Levi & Korsinsky - GlobeNewswire

Jun 16, 2025
pulisher
Jun 16, 2025

OGN SHAREHOLDER REPORT: Organon & Co. was Sued for Fraud – - GlobeNewswire

Jun 16, 2025
pulisher
Jun 16, 2025

Securities Lawsuit Alert: Organon & Co. (OGN)Contact Levi & Korsinsky Before July 22, 2025 - ACCESS Newswire

Jun 16, 2025
pulisher
Jun 16, 2025

OGN INVESTOR ALERT: Organon & Co. Investors with Substantial Losses Have Opportunity to Lead Securities Class Action Lawsuit - PR Newswire

Jun 16, 2025
pulisher
Jun 16, 2025

Class Action Lawsuit Filed Against Organon & Co. (OGN)Recover LossesContact Levi & Korsinsky Before July 22, 2025 - ACCESS Newswire

Jun 16, 2025
pulisher
Jun 16, 2025

Investors in Organon & Co. Should Contact The Gross Law Firm Before July 22, 2025 to Discuss Your RightsOGN - WV News

Jun 16, 2025
pulisher
Jun 15, 2025

Securities Class Action Lawsuit Filed Against Organon & Co. (OGN)Levi & Korsinsky Represents Shareholders - ACCESS Newswire

Jun 15, 2025

Organon Co Azioni (OGN) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading

Organon Co Azioni (OGN) insider trading

Commercio interno Relazione Data Transazione Costo #Azioni Valore ($) #Azioni Totale
Falcione Aaron
Chief Human Resources Officer
May 07 '25
Buy
8.77
5,500
48,235
62,974
Weaver Kirke
Gen. Counsel & Corp. Secy.
May 06 '25
Buy
9.21
8,045
74,054
52,489
Karp Daniel
Executive VP, Corp. Dev.
May 06 '25
Buy
8.24
3,500
28,828
46,669
WALSH MATTHEW M
Chief Financial Officer
May 05 '25
Buy
8.82
11,400
100,548
144,484
Ali Kevin
Chief Executive Officer
May 05 '25
Buy
8.80
34,000
299,370
282,731
Falcione Aaron
Chief Human Resources Officer
Mar 31 '25
Option Exercise
0.00
18,732
0
59,237
Karp Daniel
Executive VP, Corp. Dev.
Mar 31 '25
Option Exercise
0.00
34,677
0
44,515
Stahler Rachel A
Chief Information Officer
Mar 31 '25
Option Exercise
0.00
18,334
0
78,994
WALSH MATTHEW M
Chief Financial Officer
Mar 31 '25
Option Exercise
0.00
34,870
0
136,903
Arjona Ferreira Juan Camilo
Head of R&D & CMO
Mar 31 '25
Option Exercise
0.00
8,865
0
20,552
drug_manufacturers_general SNY
$48.55
price down icon 0.12%
$112.09
price up icon 2.23%
drug_manufacturers_general PFE
$25.35
price down icon 1.17%
$297.03
price up icon 0.60%
drug_manufacturers_general MRK
$83.67
price up icon 0.37%
drug_manufacturers_general NVO
$68.94
price up icon 0.01%
Capitalizzazione:     |  Volume (24 ore):